Fascin1 expression predicts poor prognosis in patients with nasopharyngeal carcinoma and correlates with tumor invasion

IF 65.4 1区 医学 Q1 ONCOLOGY Annals of Oncology Pub Date : 2010-03-01 DOI:10.1093/annonc/mdp333
D. Wu , L. Chen , W. Liao , Y. Ding , Q. Zhang , Z. Li , L. Liu
{"title":"Fascin1 expression predicts poor prognosis in patients with nasopharyngeal carcinoma and correlates with tumor invasion","authors":"D. Wu ,&nbsp;L. Chen ,&nbsp;W. Liao ,&nbsp;Y. Ding ,&nbsp;Q. Zhang ,&nbsp;Z. Li ,&nbsp;L. Liu","doi":"10.1093/annonc/mdp333","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The purpose of this study was to investigate prognostic significance of fascin1 in nasopharyngeal carcinoma (NPC) and evaluate the association of fascin1 with tumor invasion.</p></div><div><h3>Materials and methods</h3><p>Immunohistochemical staining for fascin1 was carried out on paraffin-embedded tissue sections from 161 patients with NPC. Data were subjected to statistical analysis with respect to clinicopathological variables and survival. Small interfering RNA (siRNA) approach was used to knockdown fascin1 expression in NPC cells to determine whether fascin1 contributes to tumor cell invasion.</p></div><div><h3>Results</h3><p>Immunohistochemical analysis showed that fascin1 was highly expressed in 95 (59.0%) of 161 paraffin-embedded NPC tissues. Fascin1 expression was significantly correlated with clinical stage (<em>P</em> <!-->&lt;<!--> <!-->0.001) and N classification (<em>P</em> <!-->&lt;<!--> <!-->0.001). Statistical analysis showed that fascin1 expression was inversely correlated with both overall and disease-free survival of NPC patients. Multivariate analysis showed that fascin1 expression was an independent prognostic indicator for patient's survival. Moreover, disruption of endogenous fascin1 expression in NPC cells using siRNA technique suppressed NPC cell invasiveness and decreased cell filopodia and lamellopodia.</p></div><div><h3>Conclusion</h3><p>The present study indicates that fascin1 expression is inversely correlated with NPC patient survival and directly correlated with the malignant status of NPC.</p></div>","PeriodicalId":8000,"journal":{"name":"Annals of Oncology","volume":"21 3","pages":"Pages 589-596"},"PeriodicalIF":65.4000,"publicationDate":"2010-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/annonc/mdp333","citationCount":"24","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0923753419382961","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 24

Abstract

Background

The purpose of this study was to investigate prognostic significance of fascin1 in nasopharyngeal carcinoma (NPC) and evaluate the association of fascin1 with tumor invasion.

Materials and methods

Immunohistochemical staining for fascin1 was carried out on paraffin-embedded tissue sections from 161 patients with NPC. Data were subjected to statistical analysis with respect to clinicopathological variables and survival. Small interfering RNA (siRNA) approach was used to knockdown fascin1 expression in NPC cells to determine whether fascin1 contributes to tumor cell invasion.

Results

Immunohistochemical analysis showed that fascin1 was highly expressed in 95 (59.0%) of 161 paraffin-embedded NPC tissues. Fascin1 expression was significantly correlated with clinical stage (P < 0.001) and N classification (P < 0.001). Statistical analysis showed that fascin1 expression was inversely correlated with both overall and disease-free survival of NPC patients. Multivariate analysis showed that fascin1 expression was an independent prognostic indicator for patient's survival. Moreover, disruption of endogenous fascin1 expression in NPC cells using siRNA technique suppressed NPC cell invasiveness and decreased cell filopodia and lamellopodia.

Conclusion

The present study indicates that fascin1 expression is inversely correlated with NPC patient survival and directly correlated with the malignant status of NPC.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Fascin1表达预测鼻咽癌患者预后不良,并与肿瘤侵袭相关
本研究的目的是探讨fascin1在鼻咽癌(NPC)中的预后意义,并评价其与肿瘤侵袭的关系。材料与方法对161例鼻咽癌患者石蜡包埋组织切片进行免疫组化染色。对数据进行临床病理变量和生存率的统计分析。采用小干扰RNA (Small interfering RNA, siRNA)方法敲低鼻咽癌细胞中fascin1的表达,以确定fascin1是否参与肿瘤细胞侵袭。结果免疫组化分析显示,在161个石蜡包埋的鼻咽癌组织中,有95个组织(59.0%)表达了fascin1。Fascin1表达与临床分期有显著相关性(P <0.001)和N分类(P <0.001)。统计分析显示,fascin1的表达与鼻咽癌患者的总生存率和无病生存率呈负相关。多因素分析显示,fascin1表达是患者生存的独立预后指标。此外,利用siRNA技术破坏鼻咽癌细胞中内源性fascin1的表达,抑制了鼻咽癌细胞的侵袭性,减少了细胞的丝状足和板足。结论本研究提示,fascin1表达与鼻咽癌患者生存呈负相关,与鼻咽癌恶性程度直接相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Annals of Oncology
Annals of Oncology 医学-肿瘤学
CiteScore
63.90
自引率
1.00%
发文量
3712
审稿时长
2-3 weeks
期刊介绍: Annals of Oncology, the official journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, offers rapid and efficient peer-reviewed publications on innovative cancer treatments and translational research in oncology and precision medicine. The journal primarily focuses on areas such as systemic anticancer therapy, with a specific emphasis on molecular targeted agents and new immune therapies. We also welcome randomized trials, including negative results, as well as top-level guidelines. Additionally, we encourage submissions in emerging fields that are crucial to personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Manuscripts related to radiotherapy, surgery, and pediatrics will be considered if they demonstrate a clear interaction with any of the aforementioned fields or if they present groundbreaking findings. Our international editorial board comprises renowned experts who are leaders in their respective fields. Through Annals of Oncology, we strive to provide the most effective communication on the dynamic and ever-evolving global oncology landscape.
期刊最新文献
Cabozantinib plus nivolumab and ipilimumab in previously untreated, advanced renal cell carcinoma: final results and biomarker analyses from the phase III COSMIC-313 study. Learning the Forest Before the Trees: Artificial Intelligence and Thymic Tumor Pathology. Doubting T(h)OMAS: Has the era of precision oncology arrived in uterine leiomyosarcoma? ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours. PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1